
Celebrating Women in Science: BLIS Team Members Share Their Stories
Scientific innovation is a team effort, and at BLIS, we’re proud to have a diverse group of scientists driving our research forward.
The latest updates on our probiotic developments and news.
Scientific innovation is a team effort, and at BLIS, we’re proud to have a diverse group of scientists driving our research forward.
Recent research highlights a growing connection between oral health and systemic diseases, including cognitive, cardiovascular, and even fertility issues. Maintaining periodontal health is crucial for overall wellbeing, potentially lowering the risk of severe conditions such as Alzheimer’s, heart disease, and diabetes.
We’re proud to announce our support for the IPA World Congress + Probiota 2025, taking place February 5–7 in Copenhagen.
Recent research highlights a growing connection between oral health and systemic diseases, including cognitive, cardiovascular, and even fertility issues. Maintaining periodontal health is crucial for overall wellbeing, potentially lowering the risk of severe conditions such as Alzheimer’s, heart disease, and diabetes.
Meet us at SupplySide West 2024 in Las Vegas! Connect with our team to learn more about our advanced probiotic strains for oral, throat and immune health.
Meet us at Vitafoods Asia 2024 where we will be presenting our latest probiotic innovations and clinical research.
Oral health is often thought of as simply looking after your teeth and gums, but new research has uncovered the bi-directional relationship between the oral microbiome and systemic disease.
One of the most common and painful side effects of cancer treatment is mouth sores, medical known as oral mucositis, affecting a significant percentage of patients undergoing chemotherapy and radiotherapy. Recent studies have highlighted the potential of BLIS K12™ in providing much-needed relief for this condition.
We’re partnering with the IPA World Congress + Probiota Americas this June. Join us in Salt Lake City to dive into the world of microbiome science and business.
In our latest whitepaper, a recent study shows that BLIS K12™ stimulates the production of antibodies specific to SARS CoV-2 virus in people that have been vaccinated for COVID-19 and led to accelerated viral clearance.
Otitis media, a term that may sound unfamiliar to many, refers to a common condition that affects the middle ear. This inflammation can occur in people of all ages but is particularly prevalent in children.
The recent scientific breakthroughs in understanding the interplay between the immune system, the oral microbiota, and the SARS-CoV-2 virus have paved the way for exciting revelations in the field of probiotics.